Prophylactic L-arginine and ibuprofen delay the development of tactile allodynia and suppress spinal miR-155 in a rat model of diabetic neuropathy

This publication has 71 references indexed in Scilit:

• Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy
  Biochemical and Biophysical Research Communications, 2013
• Cyclooxygenase-2 Pathway as a Potential Therapeutic Target in Diabetic Peripheral Neuropathy
  Current Drug Targets, 2008
• Pathogenesis of pain in peripheral diabetic neuropathy
  Current Diabetes Reports, 2007
• Oxidative Stress in the Pathogenesis of Diabetic Neuropathy
  Endocrine Reviews, 2004
• Nitrosative Injury and Antioxidant Therapy in the Management of Diabetic Neuropathy
  Journal of Investigative Medicine, 2004
• Advances in Neuropathic Pain
  Archives of Neurology, 2003
• High Glucose Causes Upregulation of Cyclooxygenase-2 and Alters Prostanoid Profile in Human Endothelial Cells
  Circulation, 2003
• Nerve Growth Factor and Diabetic Neuropathy
  Journal of Diabetes Research, 2003
• Elevated Spinal Cyclooxygenase and Prostaglandin Release During Hyperalgesia in Diabetic Rats
  Diabetes, 2002
• Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1- and COX2-inhibitors in nerve-injured rats ☆
  Pain, 1999